Dorothee Arenz

Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study

Oliver A. Cornely, José Miguel Cisneros, Julián Torre‐Cisneros et al. · Journal of Antimicrobial Chemotherapy · 2019 · 123 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML)

Jörg Janne Vehreschild, Angelika Böhme, Dieter Buchheidt et al. · Journal of Infection · 2007 · 98 citations

Medicine, Hematology, Pharmacotherapy +11

Phase II Dose Escalation Study of Caspofungin for Invasive Aspergillosis

Oliver A. Cornely, Jörg Janne Vehreschild, Maria J. G. T. Vehreschild et al. · Antimicrobial Agents and Chemotherapy · 2011 · 92 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Risk factors for breakthrough invasive fungal infection during secondary prophylaxis

Oliver A. Cornely, Angelika Böhme, Dietmar Reichert et al. · Journal of Antimicrobial Chemotherapy · 2008 · 70 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

EQUAL Aspergillosis Score 2018: An ECMM score derived from current guidelines to measure QUALity of the clinical management of invasive pulmonary aspergillosis

Oliver A. Cornely, Philipp Koehler, Dorothee Arenz et al. · Mycoses · 2018 · 54 citations

Medicine, Infectious Diseases, Microbiology +17